BioSpace News Archive

Genetown

Thermo Fisher Scientific Showcases Investment and Innovation During CPhI Worldwide 2021

At CPhI Worldwide 2021, Thermo Fisher Scientific will showcase its newest capabilities across its global pharma services network which help pharmaceutical and emerging biotech companies accelerate time to market

November 2, 2021
·
5 min read
Business

Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 9, 2021

Aethlon Medical, Inc., a company developing medical technology to treat cancer and life-threatening infectious disease, announced that it will issue financial results for its second quarter fiscal year 2022, ended September 30, 2021, at 4:15 p.m. EST on Tuesday, November 9, 2021.

November 2, 2021
·
3 min read
Business

OSSIO Appoints Gregory C. Berlet, MD, as Chief Medical Officer

OSSIO, Inc., an orthopedic fixation technology company, today announced the appointment of Gregory C. Berlet, MD, as its Chief Medical Officer.

November 2, 2021
·
4 min read
Biotech Beach

CytRx Highlights Orphazyme’s Update on Productive Meeting with FDA Regarding Arimoclomol in Niemann-Pick Disease Type C

CytRx Corporation today commented on Orphazyme A/S’s (NASDAQ: ORPH) (“Orphazyme”) encouraging regulatory update following its recently held Type A meeting with the U.S. Food and Drug Administration (“FDA”) on arimoclomol

November 2, 2021
·
5 min read
Biotech Bay

Twist Bioscience Named in Inc.’s First Annual Best-Led Companies List

Twist Bioscience Corporation announced that it has been included in Inc.’s first annual Best-Led Companies list, an exciting 12-point measure of management excellence across the middle market — a select, data-driven list of the very strongest U.S. firms with revenue of $50 million to $2 billion.

November 2, 2021
·
5 min read
Business

Novan Appoints Brian M. Johnson as Chief Commercial Officer and Receives Conditional FDA Acceptance of Proposed Brand Name KINSOLUS™ for SB206 in Molluscum Contagiosum

Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced the appointment of Brian M. Johnson as its Chief Commercial Officer.

November 2, 2021
·
8 min read
Business

ChemoCentryx to Hold Third Quarter 2021 Financial Results Conference Call on Tuesday, November 9, 2021

ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company’s third quarter 2021 financial results will be released after market close on Tuesday, November 9, 2021.

November 2, 2021
·
1 min read
Business

Resonant to Report Third Quarter 2021 Financial Results on Wednesday, November 10th at 3:30 P.M. Central Time

Resonant Inc will release financial results for the third quarter ended September 30th , 2021 after market close on Wednesday, November 10 th , 2021.

November 2, 2021
·
2 min read
Business

Quoin Pharmaceuticals Announces Signing of Exclusive License from Queensland University of Technology, Australia

Quoin Pharmaceuticals Ltd. today announced that it has signed an agreement with Queensland University of Technology, Australia (QUT).

November 2, 2021
·
3 min read
FDA

Landos Biopharma Announces FDA Clearance of its IND for LABP-104 for the Treatment of Rheumatoid Arthritis

Landos Biopharma, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for LABP-104, a novel, oral, systemically delivered LANCL2 agonist, for the treatment of rheumatoid arthritis (RA).

November 2, 2021
·
8 min read